|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
ocn679416674 |
| 003 |
OCoLC |
| 005 |
20240809213013.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
101108s2010 xx o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDXCP
|d OCLCQ
|d MHW
|d OCLCQ
|d ZCU
|d MERUC
|d CUY
|d OCLCO
|d ICG
|d OCLCQ
|d OCLCO
|d OCLCF
|d OCLCQ
|d DKC
|d AU@
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9781409412427
|
| 020 |
|
|
|a 1409412423
|
| 035 |
|
|
|a (OCoLC)679416674
|
| 050 |
|
4 |
|a R853.C55E67 2010
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Byrom, Bill.
|
| 245 |
1 |
0 |
|a EPro :
|b Electronic Solutions for Patient-Reported Data.
|
| 260 |
|
|
|a Farnham :
|b Ashgate Pub.,
|c 2010.
|
| 300 |
|
|
|a 1 online resource (297 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Cover; Contents; List of Figures; List of Tables; Foreword; About the Editors; List of Contributors; Introduction; 1 Recall Bias: Understanding and Reducing Bias in PRO Data Collection; 2 Cognitive Interviewing: The use of Cognitive Interviews to Evaluate ePRO Instruments; 3 Data Quality and Power in Clinical Trials: A Comparison of ePRO and Paper in a Randomized Trial; 4 Regulation and Compliance; 5 Selection of a Suitable ePRO Solution: Benefit, Cost and Risk; 6 Patient Compliance in an ePRO Environment; 7 Computerized Clinical Assessments.
|
| 505 |
8 |
|
|a 8 Diary Design Considerations: Interface Issues and Patient Acceptability9 Equivalence Testing: Validation and Supporting Evidence When Using Modified PRO Instruments; 10 ePRO Applications and Personal Mobile Phone Use: Compliance Documentation and Patient Support; 11 Future Developments and Applications: Emerging Technologies and New Approaches to Patients; Index.
|
| 520 |
|
|
|a Recently, there has been much open debate with the regulators around the use of ePRO in clinical drug submissions. US and European agencies have approved new drugs that have included ePRO data in the submission dossier, but there are many questions around the adoption of the technology that concern the community. Bill Byrom and Brian Tiplady's ePro addresses these questions, reviews the new FDA guidance, and provides a very contemporary view on this important subject.
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Clinical trials
|x Data processing.
|
| 650 |
|
0 |
|a Outcome assessment (Medical care)
|x Data processing.
|
| 650 |
|
7 |
|a Clinical trials
|x Data processing
|2 fast
|
| 700 |
1 |
|
|a Tiplady, Brian.
|
| 776 |
0 |
8 |
|i Print version:
|a Byrom, Bill.
|t EPro : Electronic Solutions for Patient-Reported Data.
|d Farnham : Ashgate Publishing Ltd, ©2010
|z 9780566087714
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=592377
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|